T-group (topology)
586.1.1 Stathmin
Ligands and drugs
379
Member domains
150
with ligand contacts (≤ 4 Å)
39.6% of members
160
with DrugDomain annotations
42.2% of members
51
with a DrugBank compound
13.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 586.1.1 belongs to X-group 586 Stathmin, which has 2 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01206 | — | — | 1 |
| DB07574 | — | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CAmetal | CALCIUM ION | 110 |
| A1L2T | ~{N}4-(1,3-benzodioxol-5-ylmethyl)-6-(1~{H}-indol-4-yl)pyrimidine-2,4-diamine | 1 |
| LVV | 4-[(4-methylphenyl)methyl]-1,4-thiazinane 1,1-dioxide | 1 |
| NUY | [4-(propan-2-yl)piperazin-1-yl](thiophen-2-yl)methanone | 1 |
| UR1 | 3-fluoro-5-methylbenzene-1-sulfonamide | 1 |
| WZP | 2-methyl-1-[4-(propan-2-yl)piperazin-1-yl]propan-1-one | 1 |
| WZY | N-(4-methoxyphenyl)glycinamide | 1 |
| X1M | 1-(6-methoxypyridin-2-yl)-N-methylmethanamine | 1 |